Pacific Medical Systems ... NEWS ...
  Tuesday, August 01st,  2006
SyntheMed, Inc. appoints Pacific Medical Systems Ltd., for Asian markets

  
 

SyntheMed, Inc. today announced the appointed Pacific Medical Systems Ltd., as their exclusive Asian distribution partner for its products. This includes China, Hong Kong, Macau, Taiwan, Korea, Singapore, Thailand, Malaysia, Brunei, Indonesia, Philippines and Vietnam.

Robert P. Hickey, President and CEO of SyntheMed, Inc., said "We are delighted to work with Pacific Medical Systems for the Asian markets, and believe the REPEL-CV™ Adhesion Barrier can gain rapid market penetration. We  received a very positive response to REPEL-CV from customers around the world at the recent AATS in Philadelphia which was well attended with many Asian participants.”
 
Jules Flach, Founder and CEO of Pacific Medical Systems said “Adhesion formation after open-heart surgical procedures is well documented, and becomes a significant complication at the point of performing a secondary procedure (re-do’s). Secondary procedures account for 15-20% of all open heart surgeries performed.  REPEL-CV™ is a Bio-Resorbable Adhesion Barrierplaced on the surface of the heart during open heart surgery to block adhesion development. REPEL-CV™ fully resorbs within 28 days. It allows safer entry during re-operation, shortens re-operation time and anesthesia exposure, reduces blood loss and tissue damage. In addition, it may have the potential to provide improved post-surgical cardiac function as the heart surface does not adhere to surrounding tissue. We are very excited about the potential of Repel-CV™ in Asia.”
 
  Mission Statement:
Pacific Medical Systems provides quality solutions for the healthcare professionals in delivering superior diagnosis and optimum patient care through cutting-edge technology.		  
 
© 2003 Pacific Medical Systems Limited. All rights reserved.